BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019;31:83-89. [PMID: 31541911 DOI: 10.1016/j.suronc.2019.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yu Y, Xu Z, Ni H, Jin M, Dai C. Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer. Oncol Lett 2023;25:73. [PMID: 36688111 DOI: 10.3892/ol.2023.13659] [Reference Citation Analysis]
2 Brown ZJ, Hewitt DB, Pawlik TM. Adjuvant Therapy of Gallbladder Cancer. Gallbladder Cancer 2023. [DOI: 10.1007/978-981-19-6442-8_4] [Reference Citation Analysis]
3 Agarwal A, Alrawaili AM, Alzalbani MK, Alanazi GK, Alanazi SK, Alenezi SAD. Immune-Markers in GallBladder Lesions and their Clinico-Diagnostic and Prognostic Significance - An Overview. Int J Pharm Res Allied Sci 2023;12:47-58. [DOI: 10.51847/nbes0vkqmp] [Reference Citation Analysis]
4 Priya R, Jain V, Akhtar J, Saklani N, Sakhuja P, Agarwal AK, Polisetty RV, Sirdeshmukh R, Kar S, Gautam P. Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer. Front Oncol 2022;12:1027914. [PMID: 36505879 DOI: 10.3389/fonc.2022.1027914] [Reference Citation Analysis]
5 Wu Y, Zhang S, Qian X, Zhu J, Zheng S, Wu J, Huang X. The Prognostic Value of Preoperative Fibrinogen in Patients with Radical Cholecystectomy. Advanced Gut & Microbiome Research 2022;2022:1-10. [DOI: 10.1155/2022/5370539] [Reference Citation Analysis]
6 Goyal B, Gupta T, Gupta S, Gupta A. Noncoding ribonucleic acids in gallbladder cancer patients. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00001-1] [Reference Citation Analysis]
7 Wang J, Wang D, Fei Z, Feng D, Zhang B, Gao P, Hu G, Li W, Huang X, Chen D, Ding X, Wu W. KIF15 knockdown suppresses gallbladder cancer development. Eur J Cell Biol 2021;100:151182. [PMID: 34781077 DOI: 10.1016/j.ejcb.2021.151182] [Reference Citation Analysis]
8 Kuipers H, de Bitter TJJ, de Boer MT, van der Post RS, Nijkamp MW, de Reuver PR, Fehrmann RSN, Hoogwater FJH. Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications. Cancers (Basel) 2021;13:5257. [PMID: 34771420 DOI: 10.3390/cancers13215257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
9 Huang CS, Xu QC, Dai C, Wang L, Tien YC, Li F, Su Q, Huang XT, Wu J, Zhao W, Yin XY. Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction. ACS Nano 2021;15:14744-55. [PMID: 34405985 DOI: 10.1021/acsnano.1c04570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang RT, Miao RC, Zhang X, Yang GH, Mu YP, Zhang ZY, Qu K, Liu C. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer. World J Gastroenterol 2021; 27(8): 692-707 [PMID: 33716448 DOI: 10.3748/wjg.v27.i8.692] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yang C, Chen J, Yu Z, Luo J, Li X, Zhou B, Jiang N. Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma. Front Oncol 2021;11:621806. [PMID: 33718182 DOI: 10.3389/fonc.2021.621806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Zhang Y, Wang H, Chen T, Wang H, Liang X, Zhang Y, Duan J, Qian S, Qiao K, Zhang L, Liu Y, Wang J. C24-Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation. Hepatology 2021;73:692-712. [PMID: 32374916 DOI: 10.1002/hep.31304] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
13 García P, Lamarca A, Díaz J, Carrera E, Roa JC, On Behalf Of The European-Latin American Escalon Consortium. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers (Basel) 2020;12:E3670. [PMID: 33297469 DOI: 10.3390/cancers12123670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ying H, Fengying S, Feng H, Yanhong W, Xianru X, Xiaolei T. Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme. Transl Oncol 2021;14:100928. [PMID: 33212417 DOI: 10.1016/j.tranon.2020.100928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Tian C, Zhang B, Ge C. Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells. Oncol Lett 2020;20:2677-88. [PMID: 32782584 DOI: 10.3892/ol.2020.11806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Sim J, Kim Y, Kim H, Bang S, Jee S, Park S, Shin SJ, Jang K. Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma. In Vivo 2020;34:125-32. [PMID: 31882471 DOI: 10.21873/invivo.11753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sahara K, Tsilimigras DI, Maithel SK, Abbott DE, Poultsides GA, Hatzaras I, Fields RC, Weiss M, Scoggins C, Isom CA, Idrees K, Shen P, Endo I, Pawlik TM; and the US Extrahepatic Biliary Malignancy Consortium. Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium. J Surg Oncol 2020;121:503-10. [PMID: 31907941 DOI: 10.1002/jso.25825] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]